Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance.
Nambiar DK, Aguilera T, Cao H, Kwok S, Kong C, Bloomstein J, Wang Z, Rangan VS, Jiang D, von Eyben R, Liang R, Agarwal S, Colevas AD, Korman A, Allen CT, Uppaluri R, Koong AC, Giaccia A, Le QT.
Nambiar DK, et al.
J Clin Invest. 2019 Dec 2;129(12):5553-5567. doi: 10.1172/JCI129025.
J Clin Invest. 2019.
PMID: 31710313
Free PMC article.